The objective of this guideline is to provide healthcare professionals with clear guidance on the clinical features of heparin-induced thrombocytopenia (HIT), the indications
for monitoring of patients on heparins for HIT, the investigation of suspected HIT and the treatment of HIT.

First published online 9 October 2012
doi: 10.1111/bjh.12059, British Journal of Haematology, 2012, 159, 528–540